Tishina, S., Dahlhaus, A., Manik, M., Mulalic, L., Murr, J., Kotliar, M., Rakhsh-Khorshid, H., Kostopoulou, M., Hocher, F., Stroh, J., Beck, J., Williams, R. M., Balta, G. G., Liu, F., Abdallah, A. T., Bebber, C. M., Reese, M., Lim, J. K. M., Quaas, A., Brägelmann, J., Pasparakis, M., Beleggia, F., Balachandran, S., Trauzold, A., Liccardi, G., Astsaturov, I., Reichert, M., Androulidaki, A., Karstedt, S. V. (2026). Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis. Nature Communications. https://doi.org/10.1038/s41467-026-73189-8